These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38240828)

  • 1. Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011-2021.
    Shankar R; Marston XL; Danielson V; Do Rego B; Lasagne R; Williams O; Groves L
    J Neurol; 2024 May; 271(5):2473-2483. PubMed ID: 38240828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterising people with focal drug-resistant epilepsy: A retrospective cohort study.
    Benoist C; Boccaletti S; Leach JP; Cattaneo A; Chaplin A; Antunes L; Heiman F; Sander JW
    Epilepsy Behav; 2023 Dec; 149():109540. PubMed ID: 38006844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of active and drug-resistant epilepsies in Northern Italy.
    Giussani G; Canelli V; Bianchi E; Franchi C; Nobili A; Erba G; Beghi E;
    Epilepsy Behav; 2016 Feb; 55():30-7. PubMed ID: 26731716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Starting a new anti-seizure medication in drug-resistant epilepsy: Add-on or substitute?
    Janmohamed M; Lawn N; Spilsbury K; Chan J; Dunne J
    Epilepsia; 2021 Jan; 62(1):228-237. PubMed ID: 33236785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of drug resistant epilepsy in adults with epilepsy attending a neurology clinic of a tertiary referral hospital in Singapore.
    Kong ST; Ho CS; Ho PC; Lim SH
    Epilepsy Res; 2014 Sep; 108(7):1253-62. PubMed ID: 24910376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis.
    Kalilani L; Sun X; Pelgrims B; Noack-Rink M; Villanueva V
    Epilepsia; 2018 Dec; 59(12):2179-2193. PubMed ID: 30426482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Standardized Mortality Ratio and Utilization of Care in US Veterans With Drug-Resistant Epilepsy Compared With All US Veterans and the US General Population.
    Haneef Z; Rehman R; Husain AM
    JAMA Neurol; 2022 Sep; 79(9):879-887. PubMed ID: 35969384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis.
    Sultana B; Panzini MA; Veilleux Carpentier A; Comtois J; Rioux B; Gore G; Bauer PR; Kwon CS; Jetté N; Josephson CB; Keezer MR
    Neurology; 2021 Apr; 96(17):805-817. PubMed ID: 33722992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of drug-resistant-epilepsy and its associated factors in patients with epilepsy.
    Mohammadzadeh P; Nazarbaghi S
    Clin Neurol Neurosurg; 2022 Feb; 213():107086. PubMed ID: 35063723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants.
    Symonds JD; Elliott KS; Shetty J; Armstrong M; Brunklaus A; Cutcutache I; Diver LA; Dorris L; Gardiner S; Jollands A; Joss S; Kirkpatrick M; McLellan A; MacLeod S; O'Regan M; Page M; Pilley E; Pilz DT; Stephen E; Stewart K; Ashrafian H; Knight JC; Zuberi SM
    Brain; 2021 Oct; 144(9):2879-2891. PubMed ID: 34687210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unanticipated improvement in seizure control in drug-resistant epilepsy- real world observations.
    Moloney PB; Costello DJ
    Seizure; 2021 Jan; 84():60-65. PubMed ID: 33285361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying the burden of generalized tonic-clonic seizures in patients with drug-resistant epilepsy.
    Sheikh SR; Thompson N; Frech F; Malhotra M; Jehi L
    Epilepsia; 2020 Aug; 61(8):1627-1637. PubMed ID: 32658343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariable prediction model of drug resistance in adult patients with generalized epilepsy from Colombia: A case-control study.
    Orozco-Hernández JP; Quintero-Moreno JF; Marín-Medina DS; Valencia-Vásquez A; Villada HC; Lizcano A; Martínez JW
    Epilepsy Behav; 2018 Nov; 88():176-180. PubMed ID: 30290326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy.
    Wallace H; Shorvon S; Tallis R
    Lancet; 1998 Dec 19-26; 352(9145):1970-3. PubMed ID: 9872246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal Quality of Life Assessment in Post-9/11 Veterans With Epilepsy: Impact of Drug Resistance, Traumatic Brain Injury, and Comorbidity.
    Gugger JJ; Kennedy E; Panahi S; Tate DF; Roghani A; Van Cott AC; Lopez MR; Altalib H; Diaz-Arrastia R; Pugh MJ
    Neurology; 2022 Apr; 98(17):e1761-e1770. PubMed ID: 35387856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rufinamide add-on therapy for refractory epilepsy.
    Panebianco M; Prabhakar H; Marson AG
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011772. PubMed ID: 29691835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends in incidence of Rolandic epilepsy, prevalence of comorbidities and prescribing trends: birth cohort study.
    Stephen J; Weir CJ; Chin RF
    Arch Dis Child; 2020 Jun; 105(6):569-574. PubMed ID: 31937568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.